Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Lifevantage Affirms FY2025 Sales Guidance from $235.00M-245.00M to $235.00M-245.00M vs $238.48M Est

Author: Benzinga Newsdesk | February 05, 2025 05:38pm
Lifevantage (NASDAQ:LFVN) affirms FY2025 sales outlook from $235.00 million-245.00 million to $235.00 million-245.00 million vs $238.48 million estimate.

Posted In: LFVN


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist